190 related articles for article (PubMed ID: 15611310)
1. How aggressive should initial therapy for rheumatoid arthritis be? The Finnish experience.
Kaarela K; Hakala M; Hannonen P; Kautiainen H; Korpela M; Leirisalo-Repo M; Luosujärvi R; Luukkainen R; Möttönen T; Puolakka K
Rheumatology (Oxford); 2005 Jan; 44(1):134-5; author reply 135-6. PubMed ID: 15611310
[No Abstract] [Full Text] [Related]
2. How aggressive should initial therapy for rheumatoid arthritis be?
Pincus T; Sokka T
Rheumatology (Oxford); 2005 Jan; 44(1):133-4; author reply 135-6. PubMed ID: 15611309
[No Abstract] [Full Text] [Related]
3. Safety of combination therapy with hydroxychloroquine, gold sodium thiomalate and methotrexate in early rheumatoid arthritis.
Biasi D; Caramaschi P; Carletto A; Pacor ML; Bambara LM
Rev Rhum Engl Ed; 1997; 64(7-9):521-2. PubMed ID: 9338941
[No Abstract] [Full Text] [Related]
4. Treatment of rheumatoid arthritis.
Stohl W; Arkfeld DG
N Engl J Med; 1996 Sep; 335(11):821-2; author reply 822-3. PubMed ID: 8778593
[No Abstract] [Full Text] [Related]
5. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rheumatoid arthritis.
Zurier RB; DeMarco DM; Liu NY
N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778595
[No Abstract] [Full Text] [Related]
7. Rheumatoid arthritis--changing theories and treatment modalities.
van de Putte LB; van Riel PL
Acta Orthop Scand Suppl; 1995 Oct; 266():10-3. PubMed ID: 8553835
[No Abstract] [Full Text] [Related]
8. Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis.
O'Dell JR; Petersen K; Leff R; Palmer W; Schned E; Blakely K; Haire C; Fernandez A
J Rheumatol; 2006 Feb; 33(2):213-8. PubMed ID: 16358366
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate: vital new information about a middle aged drug.
Giannini EH
J Rheumatol; 2002 Oct; 29(10):2031-3. PubMed ID: 12375307
[No Abstract] [Full Text] [Related]
10. Measuring the efficacy and effectiveness of rheumatoid arthritis therapy: time to change our thinking and adopt a new model.
Wolfe F; Caplan L; Michaud K
J Rheumatol; 2004 Dec; 31(12):2317-9. PubMed ID: 15570626
[No Abstract] [Full Text] [Related]
11. The changing face of rheumatoid arthritis therapy: results of serial surveys.
Mikuls TR; O'Dell J
Arthritis Rheum; 2000 Feb; 43(2):464-5. PubMed ID: 10693890
[No Abstract] [Full Text] [Related]
12. Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.
van Tuyl LH; Lems WF; Voskuyl AE; Kerstens PJ; Garnero P; Dijkmans BA; Boers M
Ann Rheum Dis; 2008 Nov; 67(11):1574-7. PubMed ID: 18625629
[TBL] [Abstract][Full Text] [Related]
13. Assessment and management of rheumatoid arthritis.
Haraoui B
J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis in a patient with Asperger's syndrome and IDDM.
Laiho K; Meckelburg K
Clin Rheumatol; 2003 Oct; 22(4-5):361-2. PubMed ID: 14576999
[No Abstract] [Full Text] [Related]
15. Rheumatoid arthritis treatment and monitoring of outcomes--where are we [corrected] in 2007?
Yazici Y; Abramson SB
Bull NYU Hosp Jt Dis; 2007; 65(4):300-5. PubMed ID: 18081549
[TBL] [Abstract][Full Text] [Related]
16. Adenosine 5'-triphosphate infusions reduced disease activity and inflammation in a patient with active rheumatoid arthritis.
Bours MJ; Peeters RH; Landewé RB; Beijer S; Arts IC; Dagnelie PC
Rheumatology (Oxford); 2010 Nov; 49(11):2223-5. PubMed ID: 20547656
[No Abstract] [Full Text] [Related]
17. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
[TBL] [Abstract][Full Text] [Related]
18. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
19. Muehrcke lines associated to active rheumatoid arthritis.
Chávez-López MA; Arce-Martínez FJ; Tello-Esparza A
J Clin Rheumatol; 2013 Jan; 19(1):30-1. PubMed ID: 23319020
[TBL] [Abstract][Full Text] [Related]
20. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
